IL71989A - L-arginine isoxicamate and pharmaceutical compositions containing it - Google Patents

L-arginine isoxicamate and pharmaceutical compositions containing it

Info

Publication number
IL71989A
IL71989A IL71989A IL7198984A IL71989A IL 71989 A IL71989 A IL 71989A IL 71989 A IL71989 A IL 71989A IL 7198984 A IL7198984 A IL 7198984A IL 71989 A IL71989 A IL 71989A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
isoxicamate
arginine
arginine isoxicamate
Prior art date
Application number
IL71989A
Other languages
English (en)
Other versions
IL71989A0 (en
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL71989A0 publication Critical patent/IL71989A0/xx
Publication of IL71989A publication Critical patent/IL71989A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C07C46/02—Preparation of quinones by oxidation giving rise to quinoid structures
    • C07C46/06—Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/46—Phenazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38—[b, e]-condensed with two six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/34—[b, e]-condensed with two six-membered rings with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/36—[b, e]-condensed, at least one with a further condensed benzene ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL71989A 1983-09-28 1984-06-01 L-arginine isoxicamate and pharmaceutical compositions containing it IL71989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53648183A 1983-09-28 1983-09-28

Publications (2)

Publication Number Publication Date
IL71989A0 IL71989A0 (en) 1984-10-31
IL71989A true IL71989A (en) 1987-10-30

Family

ID=24138678

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71989A IL71989A (en) 1983-09-28 1984-06-01 L-arginine isoxicamate and pharmaceutical compositions containing it

Country Status (13)

Country Link
EP (1) EP0140492B1 (es)
JP (1) JPS6072890A (es)
AT (1) ATE39925T1 (es)
AU (1) AU557394B2 (es)
CA (1) CA1213888A (es)
DE (1) DE3476065D1 (es)
DK (1) DK435384A (es)
ES (1) ES8606259A1 (es)
GR (1) GR80337B (es)
IL (1) IL71989A (es)
NZ (1) NZ209701A (es)
PH (1) PH20151A (es)
ZA (1) ZA845244B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83109A (en) * 1986-07-11 1992-06-21 Ciba Geigy Ag Guanidinium aspartates,their preparation and pharmaceutical compositions containing them
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
EP1455774B1 (en) * 2001-11-26 2006-03-01 Lean-Ex Ltd. Pharmaceutical composition for treating obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts

Also Published As

Publication number Publication date
DE3476065D1 (en) 1989-02-16
ATE39925T1 (de) 1989-01-15
ZA845244B (en) 1985-02-27
EP0140492B1 (en) 1989-01-11
AU3003484A (en) 1985-04-04
CA1213888A (en) 1986-11-12
DK435384A (da) 1985-03-29
EP0140492A1 (en) 1985-05-08
IL71989A0 (en) 1984-10-31
JPS6072890A (ja) 1985-04-24
DK435384D0 (da) 1984-09-12
GR80337B (en) 1985-01-14
ES535408A0 (es) 1986-04-01
ES8606259A1 (es) 1986-04-01
PH20151A (en) 1986-10-08
NZ209701A (en) 1986-12-05
AU557394B2 (en) 1986-12-18

Similar Documents

Publication Publication Date Title
AU565236B2 (en) 1,2-diaminocyclohexyl amide compounds
DE3779053D1 (es)
HUT44135A (en) Herbicide compositions containing triazol-sulfonamide derivatives as active components and process for producing the active components
YU197385A (en) Process for stabilizing nicorandyl compound
HUT47376A (en) Insecticide compositions containing /p-phenoxy-phenoxy/-methyl-heteroaromatic compounds as active components and process for producing the active components
PH21897A (en) Process for the manufacture of 1 sulfo-2-oxoazetidine derivatives
HUT45694A (en) Herbicide and growth-controllong compositions containing 5-amino-1-phenyl-pyrazoles as active components and process for producing the active components
HUT44130A (en) Herbicide compositions containing thiazolo-triazol-sulfonamide derivatives as active components and process for producing the active components
HUT44134A (en) Herbicide compositions containing triazolo-sulfonamide derivatives as active components and process for producing the active components
EP0110397A3 (en) Polyprenyl compound, process for the production thereof and drug containing the same
HUT44011A (en) Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components
HUT41984A (en) Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
DE3469360D1 (en) Process for the preparation of an n-substituted carbamoyllactam compound
IL71989A0 (en) L-arginine isoxicamate and pharmaceutical compositions containing it
NZ216366A (en) Production of 7-amino-3-alkoxymethyl-3-cephem-4-carboxylic acid derivatives
AU568694B2 (en) N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
TR23271A (tr) En asagi % 95.5 safliginda p-ksilol'un kazanilmasina mahsus usul
AU2658788A (en) Process for the stabilization of aldehydes
ZA842666B (en) Polycyclic carboxylic acid compounds,processes for the manufacture thereof and preparations containing such carboxylic acid compounds,as well as the use thereof
DE3562370D1 (en) Amide compounds, process for preparing the same and pharmaceutical compositions containing the same
EP0119546A3 (en) Process for the preparation of compounds of the 4-oxo-damascon series, and perfumes of this compound class
PT79451A (en) Process for the preparation of dust-free quinoxaline 1,4-di-n-oxides
DE3360776D1 (en) Process for the synthesis of 2,4,6-trimethyl-4-hydroxycyclohexa-2,5-dien-1-one
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees